Pro Pharmaceuticals Group supports Australian hospitals and pharmaceutical partners with critical medicine access, medicine shortages, TGA Section 19A and SAS pathways, comparator sourcing and global clinical trial supply.

Why do medicines run short? Follow the pharmaceutical supply chain from manufacturing and batch release to the hospital ward, and discover why medicine shortages occur and how alternative supply pathways can help maintain patient access.

Early signs of supply tightening are beginning to emerge across global medicine supply chains, despite no significant increase in official shortage notifications. In practice, disruption appears first in supplier behaviour, lead times, and freight complexity—well before it is reflected in formal data.

MNX Global Logistics, Our Australian Warehouse Partner, Now Part of UPS/Marken We are pleased to share that our Australian warehousing and distribution partner, MNX Global Logistics, is now officially part of the UPS/Marken Group — a globally recognised leader in temperature-controlled logistics, clinical trial supply chains, and pharmaceutical distribution. This development further strengthens our ability to provide: GDP-compliant storage for unlicensed and clinical trial me

At Pro Pharmaceuticals Group, we’re thrilled to announce a major milestone in our journey to accelerate access and transform lives worldwide. As part of our continued growth and commitment to meeting the diverse needs of our clients, we’ve established a new warehouse depot in Hamburg, Germany. This addition complements our existing Melbourne, Australia, depot, strengthening our capabilities to support our clients across the globe. Expanding to Serve You Better Our new facilit

Introduction: In the realm of healthcare, drug shortages have become a growing concern, impacting patients, healthcare providers, and pharmaceutical companies alike. One crucial factor that contributes to these shortages is the power dynamics associated with Active Pharmaceutical Ingredients (APIs). In this blog post, we will explore the role of APIs in the pharmaceutical industry and discuss how the Porter's Five Forces framework can shed light on their significance within..

Pro Pharm worked with Rohlig's team to transport from Europe an important cold chain injectable product for our Australian hospital client. The Covid-19 global situation presented challenges which were professionally addressed and managed. Since then we've continued to strengthen our cold chain and clinical logistics capabilities.

Pro PG will work with our Australian Hospital Customers, Warehouse and Logistics Partners to Recycle and Reuse our Coolpac Validated Shippers. This will save land-fill, reduce waste and lead to business savings.

Pro PG has a new S8 licensed facility to warehouse and distribute our S8 (controlled drugs) products from. This enables Pro PG to expand our offer to supply S8 products that maybe in Shortages or required by Hospitals for their patients. Pro PG is proud to have found a professional partner company to work with in this area who shares our professional standards and also Hospital focus.